Showing 1 - 10 results of 10 for search 'Stefan A Laufer', query time: 0.04s Refine Results
  1. 1
    Stimulating Effect of Sclareol on Suicidal Death of Human Erythrocytes

    Stimulating Effect of Sclareol on Suicidal Death of Human Erythrocytes by Elena Signoretto, Stefan A. Laufer, Florian Lang

    Published 2016-07-01
    Get full text
    Article
  2. 2
    Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands

    Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands by Darius P. Zlotos, Thales Kronenberger, Stefan A. Laufer

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist

    Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonist by Azam Rashidian, Enni-Kaisa Mustonen, Thales Kronenberger, Matthias Schwab, Oliver Burk, Stefan A. Laufer, Tatu Pantsar

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β Inhibitors

    Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β Inhibitors by Stanislav Andreev, Tatu Pantsar, Francesco Ansideri, Mark Kudolo, Michael Forster, Dieter Schollmeyer, Stefan A. Laufer, Pierre Koch

    Published 2019-06-01
    Get full text
    Article
  5. 5
    Discovery of Polyphenolic Natural Products as SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19

    Discovery of Polyphenolic Natural Products as SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19 by Nadine Krüger, Thales Kronenberger, Hang Xie, Cheila Rocha, Stefan Pöhlmann, Haixia Su, Yechun Xu, Stefan A. Laufer, Thanigaimalai Pillaiyar

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c‑Jun N‑Terminal Kinase 3

    Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c‑Jun N‑Terminal Kinase 3 by Francesco Ansideri, Joana T. Macedo, Michael Eitel, Ahmed El-Gokha, Dhafer S. Zinad, Camilla Scarpellini, Mark Kudolo, Dieter Schollmeyer, Frank M. Boeckler, Bärbel S. Blaum, Stefan A. Laufer, Pierre Koch

    Published 2018-07-01
    Get full text
    Article
  7. 7
    Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α production.

    Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α production. by Renata B Lacerda, Leandro L da Silva, Cleverton K F de Lima, Eduardo Miguez, Ana Luisa P Miranda, Stefan A Laufer, Eliezer J Barreiro, Carlos A M Fraga

    Published 2012-01-01
    Get full text
    Article
  8. 8
    Discovery and Evaluation of Enantiopure 9<i>H</i>-pyrimido[4,5-<i>b</i>]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability

    Discovery and Evaluation of Enantiopure 9<i>H</i>-pyrimido[4,5-<i>b</i>]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability by Stanislav Andreev, Tatu Pantsar, Ahmed El-Gokha, Francesco Ansideri, Mark Kudolo, Débora Bublitz Anton, Giulia Sita, Jenny Romasco, Christian Geibel, Michael Lämmerhofer, Márcia Ines Goettert, Andrea Tarozzi, Stefan A. Laufer, Pierre Koch

    Published 2020-10-01
    Get full text
    Article
  9. 9
    The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

    The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma by Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko, Aaron Stahl, Yvonne Rasen, Christine Geisler, Kristina Ruhm, Marion Klaumuenzer, Thales Kronenberger, Stefan A. Laufer, Holly Sundberg-Malek, Khac Cuong Bui, Marius Horger, Saskia Biskup, Klaus Schulze-Osthoff, Markus Templin, Nisar P. Malek, Antti Poso, Michael Bitzer

    Published 2024-02-01
    Get full text
    Article
  10. 10
    Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

    Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors by Florian Wittlinger, Blessing C. Ogboo, Ekaterina Shevchenko, Tahereh Damghani, Calvin D. Pham, Ilse K. Schaeffner, Brandon T. Oligny, Surbhi P. Chitnis, Tyler S. Beyett, Alexander Rasch, Brian Buckley, Daniel A. Urul, Tatiana Shaurova, Earl W. May, Erik M. Schaefer, Michael J. Eck, Pamela A. Hershberger, Antti Poso, Stefan A. Laufer, David E. Heppner

    Published 2024-02-01
    Get full text
    Article

Search Tools: